Akebia Therapeutics, Inc.
USD1.30
+0.02 (+1.55%)
CEO
John Butler
IPO Date
2014-03-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.27
Prev. Close
$1.28
Day Low
$1.27
Day High
$1.33
52W Low
$0.82
52W High
$4.04
Market Cap
$0.35B
Volume
1.07M
| 35,700 |
| $0.00 |
| 22 Jun 2026 | Wolf Myles | director | A-Award | Acquired | 53,600 | $1.02 |
| 22 Jun 2026 | Smith Cynthia | director | A-Award | Acquired | 35,700 | $0.00 |
| 22 Jun 2026 | Smith Cynthia | director | A-Award | Acquired | 53,600 | $1.02 |
| 22 Jun 2026 | ROGERS MICHAEL W | director | A-Award | Acquired | 35,700 | $0.00 |
| 22 Jun 2026 | ROGERS MICHAEL W | director | A-Award | Acquired | 53,600 | $1.02 |
| 22 Jun 2026 | FRIESON RON | director | A-Award | Acquired | 35,700 | $0.00 |
| 22 Jun 2026 | FRIESON RON | director | A-Award | Acquired | 53,600 | $1.02 |
| 22 Jun 2026 | ZUMWALT LEANNE M | director | A-Award | Acquired | 35,700 | $0.00 |